Scott D. Myers is a businessperson who has been the head of 6 different companies and holds the position of Chairman for Dynavax Technologies Corp. and Chairman at Harpoon Therapeutics, Inc. Mr. Myers is also on the board of Selecta Biosciences, Inc.

In his past career he occupied the position of Chairman & Chief Executive Officer of Rainier Therapeutics, Inc., Vice President at UCB SA, President, CEO & Head-Media Contact at Aerocrine AB, President, Chief Executive Officer & Director at Cascadian Therapeutics, Inc., President, Chief Executive Officer & Director at AMAG Pharmaceuticals, Inc. and Senior Vice President-Marketing at DOV Pharmaceutical, Inc.

Scott D. Myers received an undergraduate degree from Northwestern University and an MBA from Graduate School of Business.